CoChat

Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion

Open access
Chang, Jungshan, Shi, Patricia A., Chiang, Elaine Y., Frenette, Paul S. · 2008 · Blood
Cited by 101

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Previous studies using intravital microscopy in a sickle cell disease (SCD) mouse model suggest that adherent white blood cells (WBCs) play a key role in vaso-occlusion by capturing circulating red blood cells (RBCs) in venules. Commercial intravenous immunoglobulin (IVIG) given before the inflammatory stimuli increased microcirculatory blood flow and survival. To mimic the clinical situation in which SCD patients seek medical attention after the onset of symptoms, we developed an in vivo model in which the therapeutic intervention (eg, IVIG) was administered after in the inflammatory challenge. In this setting, IVIG rapidly (< 10 minutes) reduced adherent leukocyte numbers and dramatically inhibited interactions between RBCs and WBCs, resulting in improved microcirculatory blood flow and survival of sickle cell “Berkeley” mice. Longer survival correlated positively with blood flow (P = .001) and negatively with the number of adherent leukocytes (P = .001) and RBC-WBC interactions (P = .002). Using multichannel digital fluorescence videomicroscopy, we found that IVIG affected specifically the recruitment of neutrophils. Moreover, further analyses of leukocyte behavior revealed that IVIG significantly increased rolling velocities, indicating that it alters adhesion pathways involved in slow rolling. These data suggest that the potential therapeutic benefits of IVIG in SCD crises should be evaluated in a clinical trial.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2007-04-084061

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 38

  1. Buchanan, Sickle cell disease., Hematol Am Soc Hematol Educ Prog, 2004, 35, 10.1182/asheducation-2004.1.35 · DOI · Paper page
  2. Chiang, 2005, Sickle cell vaso-occlusion., Hematol Oncol Clin North Am, 19, 771, 10.1016/j.hoc.2005.08.002 · DOI
  3. Stuart, 2004, Sickle-cell disease., Lancet, 364, 1343, 10.1016/S0140-6736(04)17192-4 · DOI · Paper page
  4. Frenette, 2007, Sickle cell disease: old discoveries, new concepts, and future promise., J Clin Invest, 117, 850, 10.1172/JCI30920 · DOI · Paper page
  5. Pauling, 1964, Molecular disease and evolution., Bull N Y Acad Med, 40, 334
  6. Hebbel, 1980, Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease., J Clin Invest, 65, 154, 10.1172/JCI109646 · DOI · Paper page
  7. Kaul, 1989, Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiologic implications., Proc Natl Acad Sci U S A, 86, 3356, 10.1073/pnas.86.9.3356 · DOI · Paper page
  8. Mohandas, 1985, Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins., J Clin Invest, 76, 1605, 10.1172/JCI112144 · DOI
  9. Hofstra, 1996, Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst., Blood, 87, 4440, 10.1182/blood.V87.10.4440.bloodjournal87104440 · DOI · Paper page
  10. Wun, 1999, Platelet-erythrocyte adhesion in sickle cell disease., J Investig Med, 47, 121
  11. Turhan, 2002, Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm., Proc Natl Acad Sci U S A, 99, 3047, 10.1073/pnas.052522799 · DOI · Paper page
  12. Frenette, 1996, Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins., Cell, 84, 563, 10.1016/S0092-8674(00)81032-6 · DOI · Paper page
  13. Ley, 1995, Sequential contribution of L- and P-selectin to leukocyte rolling in vivo., J Exp Med, 181, 669, 10.1084/jem.181.2.669 · DOI · Paper page
  14. Weller, 1992, Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha., J Biol Chem, 267, 15176, 10.1016/S0021-9258(18)42162-X · DOI · Paper page
  15. Tavakkoli, 2004, Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea., Hematol, 9, 61, 10.1080/1024533032000158869 · DOI
  16. Malavé, 1993, Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease., Acta Haematol, 90, 172, 10.1159/000204452 · DOI · Paper page
  17. Francis, 1992, Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease., J Natl Med Assoc, 84, 611
  18. Hoppe, 2007, Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia., Stroke, 38, 2241, 10.1161/STROKEAHA.107.483115 · DOI · Paper page
  19. Turhan, 2004, Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes., Blood, 103, 2397, 10.1182/blood-2003-07-2209 · DOI · Paper page
  20. Johnson, 2005, The acute chest syndrome., Hematol Oncol Clin North Am, 19, 857, 10.1016/j.hoc.2005.08.001 · DOI
  21. Caress, 2003, The clinical features of 16 cases of stroke associated with administration of IVIg., Neurol, 60, 1822, 10.1212/01.WNL.0000068335.01620.9D · doi:10.1212/01.wnl.0000068335.01620.9d
  22. Jung, 1999, Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin., J Immunol, 162, 6755, 10.4049/jimmunol.162.11.6755 · DOI · Paper page
  23. Katayama, 2005, CD44 is a physiological E-selectin ligand on neutrophils., J Exp Med, 201, 1183, 10.1084/jem.20042014 · DOI · Paper page
  24. Chiang, 2007, Imaging receptor microdomains on leukocyte subsets in live mice., Nat Methods, 4, 219, 10.1038/nmeth1018 · DOI
  25. Frenette, 2004, Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion., Microcirculation, 11, 167, 10.1080/mic.11.2.167.177 · doi:10.1080/mic.11.2.167.177
  26. Dunne, 2002, Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1., Blood, 99, 336, 10.1182/blood.V99.1.336 · DOI · Paper page
  27. Shah, 2005, Use of i.v. immune globulin and occurrence of associated acute renal failure and thrombosis., Am J Health Syst Pharm, 62, 720, 10.1093/ajhp/62.7.720 · doi:10.1093/ajhp/62.7.720
  28. Bayry, 2003, Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases., Transfus Clin Biol, 10, 165, 10.1016/S1246-7820(03)00035-1 · DOI
  29. Bruhns, 2003, Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease., Immunity, 18, 573, 10.1016/S1074-7613(03)00080-3 · DOI · Paper page
  30. Samuelsson, 2001, Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor., Science, 291, 484, 10.1126/science.291.5503.484 · DOI · Paper page
  31. Siragam, 2006, Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells., Nat Med, 12, 688, 10.1038/nm1416 · DOI · Paper page
  32. Park-Min, 2007, FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin., Immunity, 26, 67, 10.1016/j.immuni.2006.11.010 · DOI · Paper page
  33. Crow, 2007, A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?, Blood, 109, 155, 10.1182/blood-2006-05-023796 · DOI
  34. Gill, 2005, Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin., Circulation, 112, 2031, 10.1161/CIRCULATIONAHA.105.546150 · DOI
  35. Kunkel, 1996, Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo., Circ Res, 79, 1196, 10.1161/01.RES.79.6.1196 · DOI · Paper page
  36. Hidalgo, 2007, Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44., Immunity, 26, 477, 10.1016/j.immuni.2007.03.011 · DOI · Paper page
  37. Belcher, 2005, Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice., Am J Physiol Heart Circ Physiol, 288, H2715, 10.1152/ajpheart.00986.2004 · DOI · Paper page
  38. Kaul, 2000, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice., J Clin Invest, 106, 411, 10.1172/JCI9225 · DOI · Paper page

Cited by

See all 101

Metadata

Authors
Chang, J., Shi, P. A., Chiang, E. Y., & Frenette, P. S.
Venue
Blood
Published
2008-01-15
Volume
111
Issue
2
Pages
915-923
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2088153090
Cited by
101
References
3
FWCI
3.53
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. https://app.cochat.ai/papers/10.1182/blood-2007-04-084061
The paper
Chang, J., Shi, P. A., Chiang, E. Y., & Frenette, P. S. (2008). Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. Blood. https://doi.org/10.1182/blood-2007-04-084061

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.